000 | 01627 a2200433 4500 | ||
---|---|---|---|
005 | 20250516184123.0 | ||
264 | 0 | _c20150202 | |
008 | 201502s 0 0 eng d | ||
022 | _a1432-198X | ||
024 | 7 |
_a10.1007/s00467-013-2696-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRuebner, Rebecca L | |
245 | 0 | 0 |
_aNephrotic syndrome associated with tyrosine kinase inhibitors for pediatric malignancy: case series and review of the literature. _h[electronic resource] |
260 |
_bPediatric nephrology (Berlin, Germany) _cMay 2014 |
||
300 |
_a863-9 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlioma _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aLeukemia, B-Cell _xcomplications |
650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xcomplications |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeoplasms _xcomplications |
650 | 0 | 4 |
_aNephrotic Syndrome _xchemically induced |
650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xcomplications |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadverse effects |
650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
700 | 1 | _aCopelovitch, Lawrence | |
700 | 1 | _aEvageliou, Nicholas F | |
700 | 1 | _aDenburg, Michelle R | |
700 | 1 | _aBelasco, Jean B | |
700 | 1 | _aKaplan, Bernard S | |
773 | 0 |
_tPediatric nephrology (Berlin, Germany) _gvol. 29 _gno. 5 _gp. 863-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00467-013-2696-0 _zAvailable from publisher's website |
999 |
_c23341166 _d23341166 |